108 related articles for article (PubMed ID: 29783295)
21. Capacity building for assessing new technologies: approaches to examining personalized medicine in practice.
Van Bebber SL; Trosman JR; Liang SY; Wang G; Marshall DA; Knight S; Phillips KA
Per Med; 2010 Jul; 7(4):427-439. PubMed ID: 21857867
[TBL] [Abstract][Full Text] [Related]
22. How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action.
Baird AM; Westphalen CB; Blum S; Nafria B; Knott T; Sargeant I; Harnik H; Brooke N; Wicki N; Wong-Rieger D
Health Sci Rep; 2023 Jun; 6(6):e1349. PubMed ID: 37359405
[TBL] [Abstract][Full Text] [Related]
23. Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests.
Ramsey SD; Veenstra DL; Garrison LP; Carlson R; Billings P; Carlson J; Sullivan SD
Am J Manag Care; 2006 Apr; 12(4):197-202. PubMed ID: 16610921
[TBL] [Abstract][Full Text] [Related]
24. Enabling personalized medicine through the use of healthcare information technology.
Cantor MN
Per Med; 2009 Sep; 6(5):589-594. PubMed ID: 29783305
[TBL] [Abstract][Full Text] [Related]
25. Insurance coverage for pharmacogenomic testing in the USA.
Williams MS
Per Med; 2007 Nov; 4(4):479-487. PubMed ID: 29793275
[TBL] [Abstract][Full Text] [Related]
26. Implementation of pharmacogenomics into the clinical practice of therapeutics: issues for the clinician and the laboratorian.
Wu AH; Babic N; Yeo KJ
Per Med; 2009 May; 6(3):315-327. PubMed ID: 29783510
[TBL] [Abstract][Full Text] [Related]
27. Translating pharmacogenomics into personalized medicine and drug development.
Zhang W; Chan TY; Fan L; Guo Y; Zhou HH
Per Med; 2012 Jan; 9(1):93-97. PubMed ID: 29783288
[TBL] [Abstract][Full Text] [Related]
28. A road toward better education in personalized medicine at universities and beyond.
Karlikova M; Polivka J; Strojil J; Topolcan O
Per Med; 2015 Jun; 12(3):259-267. PubMed ID: 29771646
[TBL] [Abstract][Full Text] [Related]
29. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
30. Integrating new approaches for clinical development: translational research and relative effectiveness.
Lehner JP; Epstein RS; Salimi T
J Comp Eff Res; 2012 Jan; 1(1 Suppl):15-21. PubMed ID: 24237318
[TBL] [Abstract][Full Text] [Related]
31. Innovative tests for patient-tailored treatments: demonstrating value in the age of personalized medicine.
Housman L
Per Med; 2011 Mar; 8(2):183-189. PubMed ID: 29783409
[TBL] [Abstract][Full Text] [Related]
32. The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system.
Gharani N; Keller MA; Stack CB; Hodges LM; Schmidlen TJ; Lynch DE; Gordon ES; Christman MF
Genome Med; 2013; 5(10):93. PubMed ID: 24134832
[TBL] [Abstract][Full Text] [Related]
33. What can be gained from increased early-stage interaction between regulators, payers and the pharmaceutical industry?
Wonder M
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):465-7. PubMed ID: 24820934
[TBL] [Abstract][Full Text] [Related]
34. Payers and the assessment of clinical utility for companion diagnostics.
Quinn B
Clin Pharmacol Ther; 2010 Dec; 88(6):751-4. PubMed ID: 21081944
[TBL] [Abstract][Full Text] [Related]
35. Implementation of genomic medicine in a health care delivery system: a value proposition?
Wade JE; Ledbetter DH; Williams MS
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):112-6. PubMed ID: 24619641
[TBL] [Abstract][Full Text] [Related]
36. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
37. Emerging landscape of genomics in the Electronic Health Record for personalized medicine.
Ullman-Cullere MH; Mathew JP
Hum Mutat; 2011 May; 32(5):512-6. PubMed ID: 21309042
[TBL] [Abstract][Full Text] [Related]
38. Personalized medicine: a competitor or an upgrade of evidence-based medicine?
Bereczki D
Per Med; 2012 Mar; 9(2):211-221. PubMed ID: 29758827
[TBL] [Abstract][Full Text] [Related]
39. Methodological recommendations for comparative research on the treatment of chronic wounds.
Sonnad SS; Goldsack JC; Mohr P; Tunis S
J Wound Care; 2013 Sep; 22(9):470-80. PubMed ID: 24005781
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
